Latest papers

Lymphoplasmacytic lymphoma with IgA hypergammaglobulinemia and liver involvement.

Bortezomib and Waldenstrom's macroglobulinemia

Expression of regulatory genes for lymphoplasmacytic cell differentiation in Waldenstrom Macroglobulinemia.

Cold agglutinin-mediated autoimmune hemolytic anemia in Waldenström's macroglobulinemia.

Targeting CD40 in Waldenström's macroglobulinemia.

Long-term survival in Waldenstrom macroglobulinemia: 10-year follow-up of Southwest Oncology Group-directed intergroup trial S9003.

Detection of a monoclonal gammopathy by serum index measurement.

Cytology features of Bing-Neel syndrome.

B cell neoplasms.

[Postoperative hypoparathyroidism, an assumed risk in total thyroidectomy for Graves disease].

[Complete response achieved after rituximab plus CHOP therapy in a patient with rapidly progressing Waldenstrom's macroglobulinemia].

[Treatment of Waldenström macroglobulinaemia--the experience of one centre].

Waldenström's macroglobulinemia in a 10-year stable IgG monoclonal gammopathy of undetermined significance.

Inherited and acquired variations in the hyaluronan synthase 1 (HAS1) gene may contribute to disease progression in multiple myeloma and Waldenstrom macroglobulinemia.

CDDO-imidazolide mediated inhibition of malignant cell growth in Waldenström macroglobulinemia.

The use of cell lines for the study of Waldenström's macroglobulinemia.

Immunodiagnostic capabilities of anti-free immunoglobulin light chain monoclonal antibodies.

Malignant hematopoietic cell lines: in vitro models for the study of Waldenström's macroglobulinemia.

Waldenstrom macroglobulinemia.

Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden.